Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 23 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 10544392

    Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  2. US 10544406

    Characterization of four prophage endolysins specific for clostridium perfringens

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  3. US 10544085

    Oils having antibacterial activity

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  4. US 10543257

    Lentiviral vector for treating hemoglobin disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  5. US 10532022

    Whole stablized olive mill process water, production thereof and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted

  6. US 10517890

    Triggering RNA interference with RNA-DNA and DNA-RNA nanoparticles

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  7. US 10519222

    Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  8. US 10512671

    IL-24 to treat inflammatory diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  9. US 10513542

    Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  10. US 10512673

    Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection and granulomatous disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  11. US 10513533

    Tunicamycin related compounds with anti-bacterial activity

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  12. US 10513521

    Compositions and methods for inhibiting BMP

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  13. US 10508106

    Bicyclic BET bromodomain inhibitors and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 17, 2019 · Expires Dec 12, 2039

    granted

  14. US 10501528

    Immunoglobulin single variable domain antibody against RSV prefusion F protein

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  15. US 10500264

    Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  16. US 10500269

    Human rotavirus vaccine strains and diagnostics

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  17. US 10500238

    Use of gram negative species to treat atopic dermatitis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  18. US 10501507

    Griffithsin mutants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  19. US 10494683

    Nitrate- and nitrite-reducing probiotic feed additive

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  20. US 10485792

    Sustained release delivery systems for the prevention and treatment of head and neck cancers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted

  21. US 10485771

    Methods of regulating cannabinoid receptor activity-related disorders and diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted

  22. US 10478415

    Ketone bodies to protect tissues from damage by ionizing radiation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted

  23. US 10480031

    Method for generating Retinal Pigment Epithelium (RPE) cells from Induced Pluripotent Stem Cells (IPSCs)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted

  24. US 10472412

    Bispecific multivalent fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.